GLB-001
A First-in-human, Phase 1, Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes
Filters
Save & Share
Clear Filters
Location
Explore options near your center - or near your patient's home.
MDS Centers of Excellence
Diagnosis
Purpose of Trial
Filter and find trials based on their purpose.
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Near Add Your Location
Sort by
Center of Excellence
- Accepting patients
- Show Principal Investigator
Center of Excellence
- Accepting patients
Center of Excellence
University of Kansas Cancer Center
Kansas City, KS
- Accepting patients
AMR Kansas City Oncology
Merriam, KS
- Accepting patients
Center of Excellence
Abramson Cancer Center - University of Pennsylvania (UPENN)
University of Pennsylvania
Philadelphia, PA
- Accepting patients
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
Roswell Park Cancer Institute
Buffalo, NY
- Accepting patients
Kadlec Clinic Hematology and Oncology
Kennewick, WA
- Accepting patients
- Accepting patients
- Show Principal Investigator
501 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.